{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:05:14Z","timestamp":1766484314601,"version":"3.41.2"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"DOI":"10.7759\/cureus.89077","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:11:17Z","timestamp":1753906277000},"source":"Crossref","is-referenced-by-count":2,"title":["Neuroleptic Malignant Syndrome in an Institutionalized Geriatric Patient Following Antipsychotic Switch to Quetiapine: A Fatal Outcome"],"prefix":"10.7759","author":[{"given":"Idalberto  Luis","family":"Fernandez Eng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adniel","family":"Garc\u00eda Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Blanco Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisleydis","family":"Perez Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03227-5","article-title":"Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis","volume":"19","author":"Sweileh WM","year":"2024","unstructured":"Sweileh WM. Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis. Orphanet J Rare Dis. 2024, 19:221. 10.1186\/s13023-024-03227-5","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1046-1044","article-title":"Treatment of the neuroleptic malignant syndrome in international therapy guidelines: a comparative analysis","volume":"53","author":"Sch\u00f6nfeldt-Lecuona C","year":"2020","unstructured":"Sch\u00f6nfeldt-Lecuona C, Kuhlwilm L, Cronemeyer M, et al.. Treatment of the neuroleptic malignant syndrome in international therapy guidelines: a comparative analysis. Pharmacopsychiatry. 2020, 53:51-9. 10.1055\/a-1046-1044","journal-title":"Pharmacopsychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1176\/ps.49.9.1163","article-title":"Neuroleptic malignant syndrome: a review","volume":"49","author":"Pelonero AL","year":"1998","unstructured":"Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv. 1998, 49:1163-72. 10.1176\/ps.49.9.1163","journal-title":"Psychiatr Serv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.19127\/mbsjohs.12845","article-title":"Fulminant neuroleptic malignant syndrome induced by low-dose quetiapine in an elderly patient","volume":"2","author":"\u00d6zcan T","year":"2016","unstructured":"\u00d6zcan T, Ta\u015f N, Demir EY, \u0130\u015fcanl\u0131 MD, \u00d6zdemir O, Bekta\u015f O, Y\u0131ld\u0131r\u0131m AA. Fulminant neuroleptic malignant syndrome induced by low-dose quetiapine in an elderly patient. Middle Black Sea J Health Sci. 2016, 2:22-4. 10.19127\/mbsjohs.12845","journal-title":"Middle Black Sea J Health Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfda.2018.07.003","article-title":"A rapid LC-MS\/MS method for simultaneous determination of quetiapine and duloxetine in rat plasma and its application to pharmacokinetic interaction study","volume":"27","author":"Chen X","year":"2019","unstructured":"Chen X, Liang C, Cui L, et al.. A rapid LC-MS\/MS method for simultaneous determination of quetiapine and duloxetine in rat plasma and its application to pharmacokinetic interaction study. J Food Drug Anal. 2019, 27:323-31. 10.1016\/j.jfda.2018.07.003","journal-title":"J Food Drug Anal"},{"key":"ref6","article-title":"Neuroleptic malignant syndrome","author":"Simon LV","year":"2025","unstructured":"Simon LV, Hashmi MF, Callahan AL. Neuroleptic malignant syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg B","year":"1982","unstructured":"Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982, 139:1136-9. 10.1176\/ajp.139.9.1136","journal-title":"Am J Psychiatry"},{"key":"ref8","article-title":"Functional evaluation: the Barthel Index","volume":"14","author":"Mahoney FI","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965, 14:61-5.","journal-title":"Md State Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.22cr03332","article-title":"Quetiapine-induced neuroleptic malignant syndrome","volume":"25","author":"Saraiva R","year":"2023","unstructured":"Saraiva R, C\u00f4rte-Real B, Cordeiro C, Gon\u00e7alves MJ, Abreu M, Coentre R. Quetiapine-induced neuroleptic malignant syndrome. Prim Care Companion CNS Disord. 2023, 25:46301. 10.4088\/PCC.22cr03332","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref10","unstructured":"Neuroleptic malignant syndrome. (2023). https.\/\/www.msdmanuals.com\/es\/professional\/lesiones-y-envenenamientos\/enfermedades-por-calor\/s%C3%ADndrome-neurol%C3%...."},{"key":"ref11","article-title":"Quetiapine-induced atypical neuroleptic malignant syndrome (NMS): a case report","volume":"9","author":"Charanya T","year":"2019","unstructured":"Charanya T, Aneelraj D,  Sivaprakash B, Eswaran S. Quetiapine-induced atypical neuroleptic malignant syndrome (NMS): a case report. J Clin Case Rep. 2019, 9:1-2.","journal-title":"J Clin Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23695","article-title":"A case report on neuroleptic malignant syndrome (NMS): how to approach an early diagnosis","volume":"14","author":"Paul T","year":"2022","unstructured":"Paul T, Karam A, Paul T, Loh H, Ferrer GF. A case report on neuroleptic malignant syndrome (NMS): how to approach an early diagnosis. Cureus. 2022, 14:23695. 10.7759\/cureus.23695","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(09)60115-7","article-title":"Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder","volume":"105","author":"Lu TC","year":"2006","unstructured":"Lu TC, Chen WJ, Chu PL, Wu CS, Tsai KC. Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder. J Formos Med Assoc. 2006, 105:90-3. 10.1016\/S0929-6646(09)60115-7","journal-title":"J Formos Med Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390997-neuroleptic-malignant-syndrome-in-an-institutionalized-geriatric-patient-following-antipsychotic-switch-to-quetiapine-a-fatal-outcome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:11:18Z","timestamp":1753906278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390997-neuroleptic-malignant-syndrome-in-an-institutionalized-geriatric-patient-following-antipsychotic-switch-to-quetiapine-a-fatal-outcome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.89077","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}